Background: Even though intra-cardiac cystic lesions are extremely unusual in adults, they should be considered in the differential diagnosis of patients presenting with valvular masses. Cardiac magnetic resonance imaging has emerged as modality of choice for non-invasive characterization of cardiac masses. Case presentation: We report a case of an intra-cardiac mass of the mitral valve in a 51-year old male, detected by echocardiography after transient ischemic attack and retinal artery occlusion. Cardiac magnetic resonance (CMR) imaging was performed at 3 T to evaluate and characterize the lesion prior to surgery. Diagnosis of a calcified left-ventricular pseudocyst of the mitral valve was confirmed by histological evaluation.
Background
Intra-cardiac cystic lesions are extremely unusual in adults. Classified as benign tumors predominantly involving the cardiac valves and supporting structures, intra-cardiac cysts have been recognized as a cause of intra-cavity flow obstruction, arrhythmia, and valvular dysfunction and have been associated with a risk of embolization [1] [2] [3] .
Whereas echocardiography is the mainstay imaging technique for the detection of intra-cardiac tumors, multiparametric cardiac magnetic resonance (CMR) imaging has become the modality of choice for non-invasive characterization of cardiac masses [4] . Comprehensive CMR imaging protocols for the evaluation of cardiac tumors including cine steady-state free precession (SSFP) sequences, black-blood T1-and T2-weighted turbo spin-echo (TSE) imaging with and without fat saturation before and after contrast enhancement, first-pass perfusion and early and late gadolinium enhancement (LGE) have been introduced, providing substantial information on the extent, morphology and vascularization of cardiac lesions [5] . Discrimination of intra-cardiac masses based on image signal intensity patterns, however, remains challenging because of their qualitative nature.
Techniques enabling the quantification of cardiac T1 and T2 magnetic relaxation times within reasonable breath-hold periods [6] [7] [8] [9] have yielded remarkable evidence in objective identification of ischemic and non-ischemic myocardial injuries [10] [11] [12] . As these magnetic relaxation times provide information about tissue composition on standardized scale (in milliseconds), they may have the potential to further improve the differentiation of cardiac tumors. The application of T1 and T2 mapping for characterization of intra-cardiac masses has not been reported to date.
Case presentation
A 51-year-old male with a history of smoking underwent transthoracic and transoesophagial echocardiography after a transient ischaemic attack (TIA) and right retinal artery occlusion. Echocardiography documented a mass of 26 mm × 24 mm attached to the mitral valve ( Figure 1A ), medium degree mitral and tricuspid regurgitation, and thrombosis of the aortic arch and descending aorta.
Anticoagulant therapy was immediately initiated. Complete blood count and biochemical tests, including electrolytes, kidney, heart and liver function tests were within normal limits, and repeated cultures of blood and urine were all negative. Thoracic computed tomography (CT) confirmed the presence of a calcified lesion on the mitral valve of unclear extent ( Figure 1B,C) ; no signs of thrombosis of the aorta were found. Based on recurring signs of TIA, including visual disturbance, speech problems and leftside dysaesthesia, the decision was made to excise the lesion surgically.
For pre-surgical evaluation of localization, extend and nature of the mass, the patient was referred for 3 T CMR imaging (Magnetom Trio, Siemens AG, Healthcare Sector, Erlangen, Germany). Differential diagnoses of the mass included caseous calcification of the valvular annulus, valvular calcified thrombus, calcified tumor (calcified myxoma or papillary fibroelastoma of mitral valve), or intra-cardiac cystic lesion. A comprehensive, ECG-gated CMR imaging protocol was carried out in breath-hold and included prototype T1 and T2 mapping sequences.
CMR imaging
The location and functional characteristics of the lesion were assessed from cine SSFP images covering the entire structure with gapless slices in 4-chamber and short-axis orientations as well as in 3-chamber view ( Figure 2 and movie in Additional files 1 and 2). A smooth shaped mass, adhering to the posterior papillary muscle and posterior mitral valve leaflet, which was thickened and restricted in mobility, presented in the left-ventricular cavity, inducing mitral valve regurgitation. Enclosed within a hypointense layer, it appeared hyperintense to myocardium and isointense to blood. Foci of pulsatile signals were observed in the mass, suggesting vascularization. The volume of the lesion, evaluated by manual segmentation in 4-chamber view (Argus, Siemens AG, Healthcare Sector, Erlangen, Germany), however, did not show dependence on cardiac phase (8.6 ml in systole versus 8.4 ml in diastole).
For standard tissue characterization, dark-blood-prepared T1-and T2-weighted TSE images were acquired in enddiastole. The mass was isointense to myocardium on T1-weighted images ( Figure 3A ) and hyperintense to myocardium on T2-weighted images ( Figure 3B ,C). On both, T1-weighted and T2-weighted images, the mass contained hypointense regions indicating either patchy calcification or vascularization.
Gadolinium was injected at rest as a bolus (Gd-DO3A-butrol, 0.15 mmol per kg body weight followed by 30 ml saline flush, both infused at 3 ml/s). First-pass saturation recovery gradient-echo perfusion images were acquired in three 4-chamber, four short-axis and three 3-chamber slices covering the mass. There were no signs of myocardial infiltration ( Figure 4A-C) . Semi-quantitative tissue analysis was performed by manually segmenting the lesion in 4-chamber orientation; the results showed low contrast uptake in the lesion ( Figure 4D ).
Post-contrast cine FLASH (fast low-angle shot) imaging performed in 3-chamber, 4-chamber and short-axis orientations revealed the structure as a hypointense mass When all aspects of soft-tissue signal and dynamic characteristics were considered together, the lesion could not be assigned to any of the suspected diagnoses: The morphological findings ruled out caseous calcification of the mitral valve [13] as well as valvular calcified thrombus [5] , first-pass gadolinium uptake was inconsistent with the diagnosis of an intra-cardiac cyst [5, 14] , and the lack of pronounced late gadolinium enhancement excluded the diagnoses of myxoma and papillary fibroelastoma [5, 15] . Overall, the findings mainly supported the diagnosis of a calcified intra-cardiac cyst of the mitral valve, because first pass contrast uptake was small and might have been neglected in cases of intra-cardiac cysts reported in literature (Table 1) . To further analyse the content and the observed contrast agent uptake of the lesion, pre-contrast T1 and T2 and post-contrast T1 relaxation times were evaluated from single-breath-hold modified Look-Locker inversion recovery (MOLLI) [6, 7] and T2 preparation-based T2 mapping [8, 9] sequences by manually segmenting the lesion ( Figure 6 ). Mean pre- Figure 6 Pre-contrast T2 map (A) as well as T1 maps obtained before (B) and 15 minutes after (C) contrast agent application in 4-chamber view. Mean pre-contrast T1, pre-contrast T2 and post-contrast T1 relaxation times of the lesion were 2220 ± 144 ms, 151 ± 17 ms and 925 ± 37 ms, respectively. Mean pre-contrast T1, pre-contrast T2 and post-contrast T1 relaxation times for blood were 1654 ± 47 ms, 147 ± 26 ms, and 271 ± 10 ms, and for myocardium 1144 ± 56 ms, 46 ± 4 ms, and 448 ± 25 ms, respectively. contrast T1 and T2 times of the lesion of 2220 ± 144 ms and 151 ± 17 ms, respectively. These values were larger than pre-contrast myocardial magnetic relaxation times (T1 = 1144 ± 56 ms, T2 = 46 ± 4 ms), in particular explaining the qualitative pre-contrast signal intensity characteristics of the mass on T1-and T2-weighted TSE as well as SSFP images [16] . Since the T1 time of blood derived from the left ventricular cavity with 1654 ± 47 ms was substantially below T1 of the intra-cardiac lesion, the diagnosis of a blood cyst could be excluded as older blood typically should have shorter T1 times [17] . The decrease of T1 time of the lesion after contrast agent application to 925 ± 37 ms, however, affirmed the observed low contrast agent uptake in first pass perfusion and late enhancement imaging, and so the vascularization of the mass.
Surgery and histological diagnosis
During surgery a smooth-shaped, white-yellowish mass was found on the ventricular side attached to the mitral valve and the posterior left ventricular wall ( Figure 7A ). The structure contained a cloudy fluid and presented with a villous inner wall consisting of cobblestone-shaped structures ( Figure 7B ). The mass was successfully resected and the mitral valve replaced (St. Jude). The postoperative course was uneventful. Histologic evaluation revealed a calcified pseudocystic mass of the mitral valve. Surrounded by a fibrous, calcified envelope, the wall of the lesion contained a dense layer of connective tissue with multiple occluded vessels and calcifications, without an inner epithelial layer ( Figure 7C ) and with signs of a chronic inflammatory process indicating chronic endocarditis ( Figure 7D ). Malignancy was ruled out.
Conclusions
An intra-cardiac cystic lesion can show contrast agent uptake. CMR enables evaluation of location, size, shape, mobility, and texture of an intra-cardiac lesion. T1 and T2 mapping before and after contrast agent application might provide quantitative information on the nature of a lesion's content, possibly improving the non-invasive diagnosis and differentiation of intra-cardiac tumors.
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